A citation-based method for searching scientific literature

Ercole Tagliamonte, Teresa Cirillo, Fausto Rigo, Costantino Astarita, Antonino Coppola, Carlo Romano, Nicola Capuano. Adv Ther 2015
Times Cited: 21







List of co-cited articles
211 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology.
Gilles Montalescot, Udo Sechtem, Stephan Achenbach, Felicita Andreotti, Chris Arden, Andrzej Budaj, Raffaele Bugiardini, Filippo Crea, Thomas Cuisset, Carlo Di Mario,[...]. Eur Heart J 2013
61

The effect of heart rate reduction by ivabradine on collateral function in patients with chronic stable coronary artery disease.
Steffen Gloekler, Tobias Traupe, Michael Stoller, Deborah Schild, Hélène Steck, Ahmed Khattab, Rolf Vogel, Christian Seiler. Heart 2014
40
57



Efficacy of ivabradine, a new selective I(f) inhibitor, compared with atenolol in patients with chronic stable angina.
Jean-Claude Tardif, Ian Ford, Michal Tendera, Martial G Bourassa, Kim Fox. Eur Heart J 2005
339
42

Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study.
Karl Swedberg, Michel Komajda, Michael Böhm, Jeffrey S Borer, Ian Ford, Ariane Dubost-Brama, Guy Lerebours, Luigi Tavazzi. Lancet 2010
42

Ivabradine in stable coronary artery disease without clinical heart failure.
Kim Fox, Ian Ford, Philippe Gabriel Steg, Jean-Claude Tardif, Michal Tendera, Roberto Ferrari. N Engl J Med 2014
287
42

Ivabradine improves coronary flow reserve in patients with stable coronary artery disease.
Emmanouil I Skalidis, Michalis I Hamilos, Gregory Chlouverakis, Evangelos A Zacharis, Panos E Vardas. Atherosclerosis 2011
35
38


Efficacy of ivabradine in combination with Beta-blocker versus uptitration of Beta-blocker in patients with stable angina.
E Amosova, E Andrejev, I Zaderey, U Rudenko, C Ceconi, R Ferrari. Cardiovasc Drugs Ther 2011
50
38


Coronary microvascular dysfunction: an update.
Filippo Crea, Paolo G Camici, Cathleen Noel Bairey Merz. Eur Heart J 2014
372
33


Ivabradine reduces myocardial stunning in patients with exercise-inducible ischaemia.
F Maranta, L Tondi, E Agricola, A Margonato, O Rimoldi, Paolo G Camici. Basic Res Cardiol 2015
12
50

Coronary and hemodynamic effects of S 16257, a new bradycardic agent, in resting and exercising conscious dogs.
L Simon, B Ghaleh, L Puybasset, J F Giudicelli, A Berdeaux. J Pharmacol Exp Ther 1995
139
28

Improvement of regional myocardial blood flow and function and reduction of infarct size with ivabradine: protection beyond heart rate reduction.
Gerd Heusch, Andreas Skyschally, Petra Gres, Patrick van Caster, Dustin Schilawa, Rainer Schulz. Eur Heart J 2008
112
28


Heart rate reduction by ivabradine reduces oxidative stress, improves endothelial function, and prevents atherosclerosis in apolipoprotein E-deficient mice.
Florian Custodis, Magnus Baumhäkel, Nils Schlimmer, Franka List, Christoph Gensch, Michael Böhm, Ulrich Laufs. Circulation 2008
198
28

Impact of Ivabradine on Central Aortic Blood Pressure and Myocardial Perfusion in Patients With Stable Coronary Artery Disease.
Jean-Guillaume Dillinger, Vincent Maher, Cristiana Vitale, Patrick Henry, Damien Logeart, Stephane Manzo Silberman, Guillaume Allée, Bernard I Levy. Hypertension 2015
31
28

Pleiotropic, heart rate-independent cardioprotection by ivabradine.
P Kleinbongard, N Gedik, P Witting, B Freedman, N Klöcker, G Heusch. Br J Pharmacol 2015
52
23


alpha-adrenergic coronary vasoconstriction and myocardial ischemia in humans.
G Heusch, D Baumgart, P Camici, W Chilian, L Gregorini, O Hess, C Indolfi, O Rimoldi. Circulation 2000
183
23

Vascular pathophysiology in response to increased heart rate.
Florian Custodis, Stephan H Schirmer, Magnus Baumhäkel, Gerd Heusch, Michael Böhm, Ulrich Laufs. J Am Coll Cardiol 2010
167
23

β-Blocker use and clinical outcomes in stable outpatients with and without coronary artery disease.
Sripal Bangalore, Gabriel Steg, Prakash Deedwania, Kevin Crowley, Kim A Eagle, Shinya Goto, E Magnus Ohman, Christopher P Cannon, Sidney C Smith, Uwe Zeymer,[...]. JAMA 2012
287
23

Ivabradine in combination with beta-blocker improves symptoms and quality of life in patients with stable angina pectoris: results from the ADDITIONS study.
Karl Werdan, Henning Ebelt, Sebastian Nuding, Florian Höpfner, Guido Hack, Ursula Müller-Werdan. Clin Res Cardiol 2012
53
23

Effects of ranolazine on noninvasive coronary flow reserve in patients with myocardial ischemia but without obstructive coronary artery disease.
Ercole Tagliamonte, Fausto Rigo, Teresa Cirillo, Costantino Astarita, Gaetano Quaranta, Umberto Marinelli, Archimede Caruso, Carlo Romano, Nicola Capuano. Echocardiography 2015
37
23

Long-term safety and efficacy of ivabradine in patients with chronic stable angina.
Lorenzo López-Bescós, Slavomira Filipova, Ramón Martos. Cardiology 2007
48
19


Resting heart rate in cardiovascular disease.
Kim Fox, Jeffrey S Borer, A John Camm, Nicolas Danchin, Roberto Ferrari, Jose L Lopez Sendon, Philippe Gabriel Steg, Jean-Claude Tardif, Luigi Tavazzi, Michal Tendera. J Am Coll Cardiol 2007
653
19

Effect of Ivabradine on Endothelial Function in Patients with Stable Angina Pectoris: Assessment with the Endo-PAT 2000 Device.
Lucia Jedlickova, Lucia Merkovska, Lucia Jackova, Martin Janicko, Jan Fedacko, Bozena Novakova, Anna Chmelarova, Jaroslav Majernik, Daniel Pella. Adv Ther 2015
10
40

Optimal medical therapy with or without PCI for stable coronary disease.
William E Boden, Robert A O'Rourke, Koon K Teo, Pamela M Hartigan, David J Maron, William J Kostuk, Merril Knudtson, Marcin Dada, Paul Casperson, Crystal L Harris,[...]. N Engl J Med 2007
19

Heart-rate reduction by If-channel inhibition with ivabradine restores collateral artery growth in hypercholesterolemic atherosclerosis.
Stephan H Schirmer, Achim Degen, Magnus Baumhäkel, Florian Custodis, Lisa Schuh, Michael Kohlhaas, Erik Friedrich, Ferdinand Bahlmann, Reinhard Kappl, Christoph Maack,[...]. Eur Heart J 2012
53
19


Bradycardia and atrial fibrillation in patients with stable coronary artery disease treated with ivabradine: an analysis from the SIGNIFY study.
Kim Fox, Ian Ford, Philippe Gabriel Steg, Jean-Claude Tardif, Michal Tendera, Roberto Ferrari. Eur Heart J 2015
30
19



Heart rate and use of beta-blockers in stable outpatients with coronary artery disease.
Ph Gabriel Steg, Roberto Ferrari, Ian Ford, Nicola Greenlaw, Jean-Claude Tardif, Michal Tendera, Hélène Abergel, Kim M Fox. PLoS One 2012
68
19

Angina at 1 year after myocardial infarction: prevalence and associated findings.
Thomas M Maddox, Kimberly J Reid, John A Spertus, Murray Mittleman, Harlan M Krumholz, Susmita Parashar, P Michael Ho, John S Rumsfeld. Arch Intern Med 2008
63
19

Effects of ivabradine and ranolazine in patients with microvascular angina pectoris.
Angelo Villano, Antonino Di Franco, Roberto Nerla, Alfonso Sestito, Pierpaolo Tarzia, Priscilla Lamendola, Antonio Di Monaco, Filippo Maria Sarullo, Gaetano Antonio Lanza, Filippo Crea. Am J Cardiol 2013
105
19

Effectiveness of Ivabradine Treatment in Different Subpopulations with Stable Angina in Clinical Practice: A Pooled Analysis of Observational Studies.
Karl Werdan, Stefan Perings, Ralf Köster, Malte Kelm, Thomas Meinertz, Georg Stöckl, Ursula Müller-Werdan. Cardiology 2016
11
36

Ranolazine improves angina in women with evidence of myocardial ischemia but no obstructive coronary artery disease.
Puja K Mehta, Pavel Goykhman, Louise E J Thomson, Chrisandra Shufelt, Janet Wei, Yuching Yang, Edward Gill, Margo Minissian, Leslee J Shaw, Piotr J Slomka,[...]. JACC Cardiovasc Imaging 2011
121
19


Ivabradine in chronic stable angina: Effects by and beyond heart rate reduction.
Paolo G Camici, Steffen Gloekler, Bernard I Levy, Emmanouil Skalidis, Ercole Tagliamonte, Panos Vardas, Gerd Heusch. Int J Cardiol 2016
25
19

Chronic heart rate reduction by ivabradine prevents endothelial dysfunction in dyslipidaemic mice.
A Drouin, M-E Gendron, E Thorin, M-A Gillis, F Mahlberg-Gaudin, J-C Tardif. Br J Pharmacol 2008
74
14

Heart rate reduction during exercise-induced myocardial ischaemia and stunning.
Xavier Monnet, Patrice Colin, Bijan Ghaleh, Luc Hittinger, Jean-François Giudicelli, Alain Berdeaux. Eur Heart J 2004
53
14


Augmented alpha-adrenergic constriction of atherosclerotic human coronary arteries.
D Baumgart, M Haude, G Görge, F Liu, J Ge, C Grosse-Eggebrecht, R Erbel, G Heusch. Circulation 1999
118
14

Intracoronary alpha 2-adrenergic receptor blockade attenuates ischemia in conscious dogs during exercise.
R Seitelberger, B D Guth, G Heusch, J D Lee, K Katayama, J Ross. Circ Res 1988
127
14

Contributions of heart rate and contractility to myocardial oxygen balance during exercise.
Patrice Colin, Bijan Ghaleh, Xavier Monnet, Jinbo Su, Luc Hittinger, Jean-Francois Giudicelli, Alain Berdeaux. Am J Physiol Heart Circ Physiol 2003
106
14

β-blocker therapy and cardiac events among patients with newly diagnosed coronary heart disease.
Charlotte Andersson, David Shilane, Alan S Go, Tara I Chang, Dhruv Kazi, Matthew D Solomon, Derek B Boothroyd, Mark A Hlatky. J Am Coll Cardiol 2014
77
14


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.